Combined treatment using peripheral nerve graft and FGF-1: Changes to the glial environment and differential macrophage reaction in a complete transected spinal cord

Neuroscience Letters

Volumn 433, Issue 3, 2008, Pages 163-169

  Lee, Meng Jen ^a,b   Chen, Ching Jung ^b   Cheng, Chu Hsun ^a,b   Huang, Wen Cheng ^b,c   Kuo, Huai Sheng ^b   Wu, Jau Ching ^d   Tsai, May J ^b   Huang, Ming Chao ^b,e   Chang, Wen Chi ^b   Cheng, Henrich ^b,c  

^a CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b Neurological Institute   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Astrocytic scarring; Back degeneration; FGF 1; Ketatan sulphate proteoglycan (KSPG); Macrophage; Reactive gliosis

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; FIBRONECTIN; PROTEOGLYCAN; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GLIA; GLIOSIS; IMMUNOREACTIVITY; MACROPHAGE; NERVE DEGENERATION; NERVE GRAFT; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD TRANSSECTION; WHITE MATTER;

ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FIBROBLAST GROWTH FACTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; GRAFT SURVIVAL; MACROPHAGES; NERVE REGENERATION; NEURAL PATHWAYS; NEUROGLIA; PERIPHERAL NERVES; PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TISSUE TRANSPLANTATION; TREATMENT OUTCOME; WALLERIAN DEGENERATION;

EID: 40849151868     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.067     Document Type: Article

References (31)

1. Aguayo A.J., David S., and Bray G.M. Influences of the glial environment on the elongation of axons after injury: transplantation studies in adult rodents. J. Exp. Biol. 95 (1981) 231-240
2. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 (2002) 636-640
3. Butler C.D., Schnetz S.A., Yu E.Y., Davis J.B., Temple K., Silver J., and Malouf A.T. Keratan sulfate proteoglycan phosphacan regulates mossy fiber outgrowth and regeneration. J. Neurosci. 24 (2004) 462-473
4. Cheng H., Cao Y., and Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science (New York N.Y.) 273 (1996) 510-513
5. Davies S.J., Goucher D.R., Doller C., and Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19 (1999) 5810-5822
6. Fawcett J.W., and Keynes R.J. Peripheral nerve regeneration. Annu. Rev. Neurosci. 13 (1990) 43-60
7. Fitch M.T., Doller C., Combs C.K., Landreth G.E., and Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19 (1999) 8182-8198
8. Garcia-Alias G., Lopez-Vales R., Fores J., Navarro X., and Verdu E. Acute transplantation of olfactory ensheathing cells or Schwann cells promotes recovery after spinal cord injury in the rat. J. Neurosci. Res. 75 (2004) 632-641
9. Hsu J.Y., and Xu X.M. Early profiles of axonal growth and astroglial response after spinal cord hemisection and implantation of Schwann cell-seeded guidance channels in adult rats. J. Neurosci. Res. 82 (2005) 472-483
10. Hurtado A., Moon L.D., Maquet V., Blits B., Jerome R., and Oudega M. Poly (d,l-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials 27 (2006) 430-442
11. Jones L.L., and Tuszynski M.H. Spinal cord injury elicits expression of keratan sulfate proteoglycans by macrophages, reactive microglia, and oligodendrocyte progenitors. J. Neurosci. 22 (2002) 4611-4624
12. Kuo H.S., Tsai M.J., Huang M.C., Huang W.C., Lee M.J., Kuo W.C., You L.H., Szeto K.C., Tsai I.L., Chang W.C., Chiu C.W., Ma H., Chak K.F., and Cheng H. The combination of peripheral nerve grafts and acidic fibroblast growth factor enhances arginase I and polyamine spermine expression in transected rat spinal cords. Biochem. Biophys. Res. Commun. 357 (2007) 1-7
13. Lee S.M., Yune T.Y., Kim S.J., Park D.W., Lee Y.K., Kim Y.C., Oh Y.J., Markelonis G.J., and Oh T.H. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20 (2003) 1017-1027
14. Lee Y.S., Baratta J., Yu J., Lin V.W., and Robertson R.T. AFGF promotes axonal growth in rat spinal cord organotypic slice co-cultures. J. Neurotrauma 19 (2002) 357-367
15. Lee Y.S., Hsiao I., and Lin V.W. Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J. Neurotrauma 19 (2002) 1203-1216
16. Lee Y.S., Lin C.Y., Robertson R.T., Hsiao I., and Lin V.W. Motor recovery and anatomical evidence of axonal regrowth in spinal cord-repaired adult rats. J. Neuropathol. Exp. Neurol. 63 (2004) 233-245
17. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., and Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89 (2004) 1092-1100
18. Markus A., Patel T.D., and Snider W.D. Neurotrophic factors and axonal growth. Curr. Opin. Neurobiol. 12 (2002) 523-531
19. Pataky D.M., Borisoff J.F., Fernandes K.J., Tetzlaff W., and Steeves J.D. Fibroblast growth factor treatment produces differential effects on survival and neurite outgrowth from identified bulbospinal neurons in vitro. Exp. Neurol. 163 (2000) 357-372
20. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., and Bunge M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10 (2004) 610-616
21. Perry V.H., and Brown M.C. Role of macrophages in peripheral nerve degeneration and repair. BioEssays 14 (1992) 401-406
22. Popovich P.G., Guan Z., Wei P., Huitinga I., van Rooijen N., and Stokes B.T. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp. Neurol. 158 (1999) 351-365
23. Popovich P.G., Wei P., and Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377 (1997) 443-464
24. Ribotta M.G., Menet V., and Privat A. Glial scar and axonal regeneration in the CNS: lessons from GFAP and vimentin transgenic mice. Acta Neurochirurgica 89 (2004) 87-92
25. Sandvig A., Berry M., Barrett L.B., Butt A., and Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 46 (2004) 225-251
26. Schwartz M., and Yoles E. Immune-based therapy for spinal cord repair: autologous macrophages and beyond. J. Neurotrauma 23 (2006) 360-370
27. Teng Y.D., Mocchetti I., and Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci. 10 (1998) 798-802
28. Tofaris G.K., Patterson P.H., Jessen K.R., and Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J. Neurosci. 22 (2002) 6696-6703
29. Vargas M.R., Pehar M., Cassina P., Martinez-Palma L., Thompson J.A., Beckman J.S., and Barbeito L. Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J. Biol. Chem. 280 (2005) 25571-25579
30. Walicke P.A. Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8 (1988) 2618-2627
31. Weaver L.C., Gris D., Saville L.R., Oatway M.A., Chen Y., Marsh D.R., Hamilton E.F., and Dekaban G.A. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. J. Neurotrauma 22 (2005) 1375-1387